相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Life histories of myeloproliferative neoplasms inferred from phylogenies
Nicholas Williams et al.
NATURE (2022)
Double L611S/V617F JAK2 mutation in a child with erythrocytosis
Benjamin Lebecque et al.
PEDIATRIC BLOOD & CANCER (2021)
Myeloproliferative Neoplasms: The Long Wait for JAK2-Mutant Clone Expansion
Damien Luque Paz et al.
CELL STEM CELL (2021)
Reconstructing the Lineage Histories and Differentiation Trajectories of Individual Cancer Cells in Myeloproliferative Neoplasms
Debra Van Egeren et al.
CELL STEM CELL (2021)
Hematopoietic stem cell heterogeneity is linked to the initiation and therapeutic response of myeloproliferative neoplasms (vol 28, pg 502, 2021)
Jingyuan Tong et al.
CELL STEM CELL (2021)
Ruxolitinib and interferon-α2 combination therapy for patients with polycythemia vera or myelofibrosis: a phase II study
Anders Lindholm Sorensen et al.
HAEMATOLOGICA (2020)
Splicing factor YBX1 mediates persistence of JAK2-mutated neoplasms
Ashok Kumar Jayavelu et al.
NATURE (2020)
Bi-allelic CSF1R Mutations Cause Skeletal Dysplasia of Dysosteosclerosis-Pyle Disease Spectrum and Degenerative Encephalopathy with Brain Malformation
Long Guo et al.
AMERICAN JOURNAL OF HUMAN GENETICS (2019)
Ruxolitinib in combination with prednisone and nilotinib exhibit synergistic effects in human cells lines and primary cells from myeloproliferative neoplasms
Alicia Arenas Cortes et al.
HAEMATOLOGICA (2019)
Germline JAK2 L611S mutation in a child with thrombocytosis
Bernard Aral et al.
HAEMATOLOGICA (2018)
Germline JAK2 L611S mutation in a child with thrombocytosis
Bernard Aral et al.
HAEMATOLOGICA (2018)
Arber DA, Orazi A, Hasserjian R, et al. The 2016 revision to the World Health Organization classification of myeloid neoplasms and acute leukemia. Blood. 2016;127(20):2391-2405.
BLOOD (2016)
JAK2 and genomic instability in the myeloproliferative neoplasms: A case of the chicken or the egg?
Linda M. Scott et al.
AMERICAN JOURNAL OF HEMATOLOGY (2012)
Detection of JAK2 mutations in paraffin marrow biopsies by high resolution melting analysis: identification of L611S alone and in cis with V617F in polycythemia vera
Roberto H. Nussenzveig et al.
LEUKEMIA & LYMPHOMA (2012)
JAK2 mutation and disease phenotype: a double L611V/V617F in cis mutation of JAK2 is associated with isolated erythrocytosis and increased activation of AKT and ERK1/2 rather than STAT5
C. Cleyrat et al.
LEUKEMIA (2010)
Substitution of pseudokinase domain residue Val-617 by large non-polar amino acids causes activation of JAK2
Alexandra Dusa et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2008)
Jak2 FERM domain interaction with the erythropoietin receptor regulates Jak2 kinase activity
Megumi Funakoshi-Tago et al.
MOLECULAR AND CELLULAR BIOLOGY (2008)
Mechanisms of disease: The myeloproliferative disorders
Peter J. Campbell et al.
NEW ENGLAND JOURNAL OF MEDICINE (2006)
A gain-of-function mutation of JAK2 in myeloproliferative disorders
R Kralovics et al.
NEW ENGLAND JOURNAL OF MEDICINE (2005)
分享论文
